• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    WeightWatchers for Business and Personify Health Partner to Help Employers Address Weight Health Care

    5/1/24 9:00:00 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary
    Get the next $WW alert in real time by email

     

    NEW YORK and PROVIDENCE, R.I., May 01, 2024 (GLOBE NEWSWIRE) -- WeightWatchers (NASDAQ:WW), ("WeightWatchers," "WW," or the "Company") today announced that WeightWatchers for Business is partnering with Personify Health (formerly Virgin Pulse) to support employers looking to provide weight health care solutions for their populations. Now, organizations using the Personify Health personalized health platform will have integrated access to WeightWatchers for Business and its full-spectrum weight health platform, which is customizable to support benefit coverage decisions. The spectrum of care is flexible and can grow in intensity from behavioral to medical interventions and a combination thereof for users on the platform, providing individualized pathways according to true clinical need.

    "Obesity is a serious and costly, yet common issue. Employers are well-positioned to play an important role in helping their employees manage their weight and improve their overall health, but they can't go it alone," said Jeffrey Jacques, MD, chief medical officer at Personify Health. "WeightWatchers has evolved with the latest research and science, and we recognize their recent innovations to provide scalable and flexible health solutions that address key aspects of weight health. We're proud to add WeightWatchers for Business to our partner ecosystem, providing an array of tools to help members achieve their desired personalized weight health and cardiometabolic goals."

    Highlights of the full-spectrum WeightWatchers for Business platform that allows users to achieve their desired results include:

    • WeightWatchers' science-backed behavior-change programs for sustained outcomes, as well as weight health behavioral programs tailored to those living with diabetes and those on GLP-1 medications.
    • Access to virtual clinic care and medication management for those eligible, including GLP-1s and other anti-obesity medications, when appropriate and based on employer coverage, under the guidance of board-certified clinicians as well as registered dietitians, fitness specialists, and care coordinators.
    • Robust virtual and real-life communities and coaching support at scale.
    • Integrated health insights for real-time data access and analysis.

    WeightWatchers for Business has been a B2B partner for more than 35 years, with experience spanning 500+ businesses across all industries. With its science-backed weight health care platform, WeightWatchers for Business supports all acuity levels, taking a weight health first approach and optimized for those members living with overweight, obesity, pre-diabetes, diabetes, hypertension, and hyperlipidemia. Additionally, the platform combines the power of WeightWatchers' behavior change program with WeightWatchers Clinic¹ to produce effective and sustainable results. Results include members seeing a 19.4% average weight loss at 12 months², 80% maintained weight loss when switching from GLP-1 to lower-cost medications³, and among members with high blood pressure at baseline, 85% of members achieved normal blood pressure at six months⁴.

    "We're grateful for our partnership with Personify Health and proud to work alongside them as one of the most innovative leaders in the industry," said Rémi Cossart, Head of WeightWatchers Clinic and WeightWatchers for Business. "We understand the importance of weight health care and the needs of organizations, and are excited to open up access to Personify Health's network to help eliminate weight bias, maximize personalized health outcomes, and ensure quality care."

    Personify Health's comprehensive partner ecosystem helps organizations close gaps in care across 25+ health and wellbeing categories while addressing the most common and costly health concerns. Companies using the Personify platform can choose to have access to WeightWatchers for Business to support the weight health care needs of their employees, complementing the impactful guidance from 200 coaches and actionable weight management content Personify offers.

    About WW International, Inc.

    WeightWatchers is a human-centric technology company powered by our proven, science-based, clinically effective weight loss and weight management programs. For six decades, we have inspired millions of people to adopt healthy habits for real life. We combine technology and community to help members reach and sustain their goals on our programs. To learn more about the WeightWatchers approach to healthy living, please visit ww.com. For more information about our global business, visit our corporate website at corporate.ww.com.

    About Personify Health

    Virgin Pulse and HealthComp have merged to become Personify Health, the company driven to engage and empower people to live healthier lives. By bringing industry-leading health plan administration, holistic wellbeing, and navigation solutions together, all in one place, we have created the industry's first and only personalized health platform. With decades of experience and global operations, we empower diverse and unique businesses – and diverse and unique people – to engage more deeply in health at a lower cost. Through our proprietary combination of data-driven personalization, science-backed methodology, and concierge-level clinical expertise, our end-to-end platform makes it easier to proactively address people's needs across their lives. With a personalized, holistic, and powerfully simple experience, we are redefining industry expectations and what it means to manage health. Learn more at www.personifyhealth.com.

    For more information, contact:

    Media Enquiries: [email protected]

    Investors:

    Corey Kinger: [email protected]

    _______________________________________

    ¹ WeightWatchers Clinic provides access to medical care through independent, affiliated medical practitioners.

    ² Based on a sample of 6,089 WeightWatchers Clinic members with 12 months of data collected from 2022 – 2023. Manuscript under review.

    ³ An observational study using member data conducted in 2024 among 207 WW Clinic members who switched from a second generation GLP-1 medication to bupropion, naltrexone, or metformin maintained their weight loss within 3 pounds or lost additional weight 13 weeks later.

    ⁴ An observational study using member data conducted in 2024 among 943 WW Clinic members with blood pressure data at baseline and at 6 months and who had hypertension at baseline, 85% of those were normotensive at 6 months on WW Clinic.

     



    Primary Logo

    Get the next $WW alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $WW

    DatePrice TargetRatingAnalyst
    9/15/2025Market Perform
    CJS Securities
    7/26/2024$6.50 → $1.25Overweight → Equal-Weight
    Morgan Stanley
    1/3/2024$8.00Underweight
    Barclays
    12/20/2023$14.00Buy
    Guggenheim
    9/27/2023$4.00 → $10.00Sell → Hold
    Craig Hallum
    7/26/2023$5.00 → $13.00Equal-Weight → Overweight
    Morgan Stanley
    4/11/2023$3.80 → $13.00Neutral → Buy
    Goldman
    3/8/2023$4.00Hold → Sell
    Craig Hallum
    More analyst ratings

    $WW
    SEC Filings

    View All

    SEC Form 8-K filed by WW International Inc.

    8-K - WW INTERNATIONAL, INC. (0000105319) (Filer)

    4/20/26 7:35:07 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    SEC Form 8-K filed by WW International Inc.

    8-K - WW INTERNATIONAL, INC. (0000105319) (Filer)

    4/17/26 5:00:14 PM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    Amendment: SEC Form 8-K/A filed by WW International Inc.

    8-K/A - WW INTERNATIONAL, INC. (0000105319) (Filer)

    4/9/26 7:35:06 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    $WW
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Hawks Carney bought $643,464 worth of shares (29,057 units at $22.14) (SEC Form 4)

    4 - WW INTERNATIONAL, INC. (0000105319) (Issuer)

    11/20/25 4:01:04 PM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    Director Kelly Denis F bought $49,897 worth of shares (64,500 units at $0.77), increasing direct ownership by 80% to 145,421 units (SEC Form 4)

    4 - WW INTERNATIONAL, INC. (0000105319) (Issuer)

    8/8/24 4:13:04 PM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    Chief Executive Officer Sistani Sima bought $48,555 worth of shares (65,000 units at $0.75), increasing direct ownership by 32% to 267,410 units (SEC Form 4)

    4 - WW INTERNATIONAL, INC. (0000105319) (Issuer)

    8/8/24 4:06:22 PM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    $WW
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Weight Watchers Appoints Proven Healthcare Executive Heather Thiltgen to Board of Directors

    NEW YORK, April 20, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("Weight Watchers" or the "Company"), the global leader in science-backed weight management, today announced that it has appointed Heather Thiltgen to the Company's Board of Directors, effective April 20, 2026. Ms. Thiltgen currently serves as the President of Presbyterian Health Plan and previously served as President & CEO of WellSense Health Plan. As Weight Watchers expands its integrated weight health platform, Ms. Thiltgen brings decades of successful healthcare leadership experience with expertise in: Expanding coverage and access to GLP-1 therapies;Navigating complex regulatory environments, including

    4/20/26 7:30:00 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    Weight Watchers Launches Eli Lilly and Company's New Oral GLP-1 Foundayo® Available Through LillyDirect

    NEW YORK, April 09, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("Weight Watchers"), the global leader in science-backed weight management, announced that it is now offering access to Eli Lilly and Company's newly FDA-approved oral GLP-1, Foundayo® (orforglipron) through its Med+ offering and affiliated medical groups. The addition gives members a new once-daily, injection-free option for adults with obesity or overweight with weight-related medical problems and further expands the company's growing portfolio of FDA-approved oral GLP-1 treatments, all within a clinically supported program designed to help them succeed. Through Weight Watchers Med+, clinically eligible memb

    4/9/26 9:00:00 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    Weight Watchers Announces Board Committee Appointments

    NEW YORK, April 09, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("Weight Watchers" or the "Company"), the global leader in science-backed weight management, today announced the following updates to the composition of its Board of Directors' standing committees following the appointments of Lisa Gavales and Sue Gove as independent directors: Audit Committee: Gene Davis (Chair), Sue Gove, Carney Hawks and Nikolaj Sjoqvist;Compensation and Benefits Committee: Carney Hawks (Chair), Gene Davis and Lisa Gavales;Nominating and Corporate Governance Committee: Nikolaj Sjoqvist (Chair), Gene Davis and Sue Gove; andStrategy and Finance Committee: Gene Davis (Chair), Lisa Gavales, Car

    4/9/26 7:30:00 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    $WW
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Cotter Debra

    4 - WW INTERNATIONAL, INC. (0000105319) (Issuer)

    4/17/26 6:01:03 PM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    SEC Form 3 filed by new insider Cotter Debra

    3 - WW INTERNATIONAL, INC. (0000105319) (Issuer)

    4/17/26 6:00:04 PM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    SEC Form 3 filed by new insider Gavales Lisa A

    3 - WW INTERNATIONAL, INC. (0000105319) (Issuer)

    4/17/26 5:59:04 PM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    $WW
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    CJS Securities initiated coverage on WW

    CJS Securities initiated coverage of WW with a rating of Market Perform

    9/15/25 10:08:29 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    WW downgraded by Morgan Stanley with a new price target

    Morgan Stanley downgraded WW from Overweight to Equal-Weight and set a new price target of $1.25 from $6.50 previously

    7/26/24 7:46:12 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    Barclays initiated coverage on WW with a new price target

    Barclays initiated coverage of WW with a rating of Underweight and set a new price target of $8.00

    1/3/24 8:36:04 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    $WW
    Financials

    Live finance-specific insights

    View All

    Weight Watchers Announces Fourth Quarter and Full Year 2025 Results

    2025 Total Revenue and Adjusted EBITDA1,2 above high end of previously provided guidance Total End of Period Subscribers of 2.8 million; End of Period Clinical Subscribers of 130 thousand, up 42% year-over-year with continued growth in first quarter 2026  Fourth Quarter Total Revenue of $163 million; Clinical Subscription Revenue of $27 million, up 32% year-over-year Fourth Quarter Net Loss of $6 million; Net Loss Margin of 3.6%; Adjusted EBITDA1 of $18 million and Adjusted EBITDA Margin1 of 11.1% Provides First Quarter 2026 End of Period Subscriber Estimates and Full Year 2026 Financial Guidance NEW YORK, March 16, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("Weigh

    3/16/26 7:00:00 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    Weight Watchers Schedules Fourth Quarter and Full Year 2025 Earnings Conference Call

    NEW YORK, Feb. 27, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("Weight Watchers" or the "Company") will release its results for the fourth quarter and full year 2025 ended December 31, 2025 before market open on Monday, March 16, 2026. Weight Watchers will host a conference call to discuss results at 8:30 a.m. ET the same day. The webcast of the conference call will be available on the Company's corporate website, corporate.ww.com, under Events and Presentations. A replay of the webcast will be available on this site for at least 90 days. About Weight WatchersWeight Watchers is the global leader in science-backed weight management, offering an integrated support system b

    2/27/26 4:01:00 PM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    WeightWatchers Schedules Third Quarter 2025 Earnings Conference Call

    NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("WeightWatchers," "WW," or the "Company") will release its results for the third quarter 2025 ended September 30, 2025, before market open on Thursday, November 6, 2025. WeightWatchers will host a conference call to discuss results at 8:30 a.m. ET the same day. The webcast of the conference call will be available on the Company's corporate website, corporate.ww.com, under Events and Presentations. A replay of the webcast will be available on this site for at least 90 days. About WeightWatchersWeightWatchers is the global leader in science-backed weight management, offering an integrated support system that co

    10/30/25 9:00:00 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    $WW
    Leadership Updates

    Live Leadership Updates

    View All

    Weight Watchers Appoints Proven Healthcare Executive Heather Thiltgen to Board of Directors

    NEW YORK, April 20, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("Weight Watchers" or the "Company"), the global leader in science-backed weight management, today announced that it has appointed Heather Thiltgen to the Company's Board of Directors, effective April 20, 2026. Ms. Thiltgen currently serves as the President of Presbyterian Health Plan and previously served as President & CEO of WellSense Health Plan. As Weight Watchers expands its integrated weight health platform, Ms. Thiltgen brings decades of successful healthcare leadership experience with expertise in: Expanding coverage and access to GLP-1 therapies;Navigating complex regulatory environments, including

    4/20/26 7:30:00 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    Weight Watchers Appoints Lisa Gavales and Sue Gove to Board of Directors

    NEW YORK, April 07, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("Weight Watchers" or the "Company"), the global leader in science-backed weight management, today announced that it has appointed accomplished executives, Lisa Gavales and Sue Gove, as independent members of the Company's Board of Directors, effective April 7, 2026. Ms. Gavales and Ms. Gove will serve as directors until the Company's 2026 annual meeting of shareholders and are expected to stand for election at the annual meeting. Following these appointments, the Board consists of six directors, all of whom are independent. Lisa Gavales and Sue Gove are highly regarded consumer brand leaders with distinct exp

    4/7/26 7:30:00 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    Weight Watchers Announces Leadership Transition and Board Updates

    Office of the CEO Established to Oversee Business Operations  Board Forms Transition Committee and Commences CEO Search NEW YORK, April 03, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("Weight Watchers" or the "Company"), the global leader in science-backed weight management, today announced leadership and governance changes, including the establishment of an Office of the CEO and the formation of a new Transition Committee of the Board of Directors ("the Board"). These actions follow Tara Comonte's departure from the Company, effective March 31, 2026.  The Company's Board of Directors has initiated a comprehensive search for a permanent successor with the support of a l

    4/3/26 2:09:00 PM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    $WW
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by WW International Inc.

    SC 13G/A - WW INTERNATIONAL, INC. (0000105319) (Subject)

    11/14/24 6:06:51 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by WW International Inc.

    SC 13G/A - WW INTERNATIONAL, INC. (0000105319) (Subject)

    11/8/24 10:40:45 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    SEC Form SC 13G filed by WW International Inc.

    SC 13G - WW INTERNATIONAL, INC. (0000105319) (Subject)

    2/14/24 6:58:51 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary